Thor Medical ASA Logo

Thor Medical ASA

Sustainably produces alpha-emitters from thorium for cancer therapies, without nuclear reactors.

NANOV | OL

Overview

Corporate Details

ISIN(s):
NO0010597883 (+1 more)
LEI:
5967007LIEEXZXG6DK30
Country:
Norway
Address:
Drammensveien 167, 0277 Oslo
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Thor Medical ASA is an emerging producer and supplier of radionuclides for medical use, specializing in alpha-particle emitters for targeted alpha therapies in oncology. The company has developed a proprietary technology for manufacturing these isotopes by separating naturally occurring radioactive decay products from thorium. This novel process eliminates the need for nuclear reactors or cyclotrons, providing a more efficient, cost-competitive, and environmentally sustainable alternative to traditional production methods.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-22 08:00
Report Publication Announcement
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at…
English 50.3 KB
2025-08-22 08:00
Report Publication Announcement
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at…
English 2.1 KB
2025-08-04 07:30
Business and Financial Review
Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228 - …
English 64.1 KB
2025-08-04 07:30
Business and Financial Review
Thor Medical and AdvanCell expand strategic supply agreement for Thorium-228
English 7.7 KB
2025-08-01 08:58
Declaration of Voting Results & Voting Rights Announcements
Thor Medical ASA - Share capital increase in relation to Subsequent Offering is…
English 46.1 KB
2025-08-01 08:58
Share Issue/Capital Change
Thor Medical ASA - Share capital increase in relation to Subsequent Offering is…
English 2.0 KB
2025-07-04 10:41
Share Issue/Capital Change
Thor Medical ASA: Final results of the Subsequent Offering - Attachment: Downlo…
Norwegian 59.1 KB
2025-07-04 10:41
Share Issue/Capital Change
Thor Medical ASA: Final results of the Subsequent Offering
Norwegian 10.1 KB
2025-07-03 07:00
Share Issue/Capital Change
Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16…
Norwegian 62.0 KB
2025-07-03 07:00
Share Issue/Capital Change
Thor Medical ASA: The Subscription Period in the Subsequent Offering ends at 16…
English 10.1 KB
2025-06-26 14:33
Director's Dealing
Thor Medical ASA: Primary insider notification and disclosure of large sharehol…
English 120.0 KB
2025-06-26 14:33
Major Shareholding Notification
Thor Medical ASA: Primary insider notification and disclosure of large sharehol…
English 51.7 KB
2025-06-26 14:33
Major Shareholding Notification
Thor Medical ASA: Primary insider notification and disclosure of large sharehol…
English 3.9 KB
2025-06-26 14:24
Share Issue/Capital Change
Thor Medical ASA - Share capital increase in relation to the Private Placement …
English 48.3 KB
2025-06-26 14:24
Declaration of Voting Results & Voting Rights Announcements
Thor Medical ASA - Share capital increase in relation to the Private Placement …
English 2.3 KB

Automate Your Workflow. Get a real-time feed of all Thor Medical ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Thor Medical ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.